Funder
Beijing Nova Program
National Natural Science Foundation of China
Reference49 articles.
1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008
2. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N. Engl. J. Med.,2020
3. Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study;Oh;Lancet Gastroenterol,2022
4. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献